Back to Top

European Neuropsychopharmacology (ENP)

Publisher :

Elsevier B.V.

Scopus Profile
Peer reviewed only
Scopus Profile
Open Access
  • Pharmacology
  • Biological Psychiatry
  • Psychiatry
  • +4

e-ISSN :

1873-7862

Issue Frequency :

Monthly

Impact Factor :

6.1

p-ISSN :

0924-977X

Est. Year :

1990

Mobile :

31204853767

Country :

Netherlands The

Language :

English

APC :

YES

Impact Factor Assignee :

Google Scholar

Email :

ENP@elsevier.com

Journal Descriptions

An Official Journal of the European College of Neuropsychopharmacology European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery. European Neuropsychopharmacology is the official journal of the European College of Neuropsychopharmacology (ECNP). Electronic usage: An increasing number of readers access the journal online via ScienceDirect, one of the world's most advanced web delivery systems for scientific, technical and medical information. Average monthly article downloads for this journal: 29,000


European Neuropsychopharmacology (ENP) is :

International, Peer-Reviewed, Open Access, Refereed, Pharmacology, Biological Psychiatry, Psychiatry, Mental Health, Psychology, Neurology, Clinical Neurology , Online or Print, Monthly Journal

UGC Approved, ISSN Approved: P-ISSN - 0924-977X, E-ISSN - 1873-7862, Established in - 1990, Impact Factor - 6.1

Not Provide Crossref DOI

Indexed in Scopus, WoS

Not indexed in DOAJ, PubMed, UGC CARE

Publications of ENP

Multi-omics data integration methods and their applications in psychiatric disorders

To study mental illness and health, in the past researchers have often broken down their complexity into individual subsystems (e.g., genomics, transcriptomics, proteomics, clinical data) an...

Multi-omics data integration methods and their applications in psychiatric disorders

To study mental illness and health, in the past researchers have often broken down their complexity into individual subsystems (e.g., genomics, transcriptomics, proteomics, clinical data) an...

  • dott image February, 2022

Transcriptional biomarkers of response to pharmacological treatments in severe mental disorders: A systematic review

Variation in the expression level and activity of genes involved in drug disposition and action in tissues of pharmacological importance have been increasingly investigated in patients treat...

  • dott image Graham Murray
  • dott image August, 2019

SA97COMPUTATIONAL PSYCHIATRY MEETS GENETICS: REINFORCEMENT LEARNING IN EARLY PSYCHOSIS AND IN RELATION TO CLINICAL AND MOLECULAR GENETIC RISK FOR SCHI...

Computational psychiatry offers opportunities for increased mechanistic understanding of mental disorder and to aid in the integration between psychiatry and neuroscience. By developing an...

  • dott image February, 2019

F133INVESTIGATING THE PHENOTYPIC MANIFESTATION OF SCHIZOPHRENIA WITH REGARDS TO GENERAL AND SPECIFIC PSYCHOPATHOLOGY IN ADOLESCENCE USING A BIFACTOR M...

Background: There is growing support for a hierarchical structure of first and higher-order dimensions of psychopathological symptoms, however, little is known about how these dimensions rel...

  • dott image September, 2016

A systematic review and meta-analysis of randomised controlled trials of treatments for clozapine-induced obesity and metabolic syndrome

Metabolic complications are commonly found in people treated with clozapine. Reviews on the management of this problem have generally drawn conclusions by grouping different types of studies...

  • dott image June, 2016

Association of birth weight and the development of antipsychotic induced adiposity in individuals with treatment resistant schizophrenia

Though weight gain is a common side effect of antipsychotic treatment, there are no useful predictors of which patients are likely to be affected and to what degree. It has been shown that e...

  • dott image January, 2015

Cross-sex hormone treatment in male-to-female transsexual persons reduces serum brain-derived neurotrophic factor (BDNF)

Serum levels of brain-derived neurotrophic factor (BDNF) are reduced in male-to-female transsexual persons (MtF) compared to male controls. It was hypothesized before that this might reflect...

Establish Your Own Journal Without the Expense!

OJSCloud offers a complete, free setup to get you publishing.

Start Your Free Journal!
free profile